BRCA2 and ovarian cancer: The frequency of BRCA2 mutations identified in this population compared to similar studies targeting breast/ovarian cancer families indicates that the stomach/breast constellation may be a more specific phenotypic marker for BRCA2 mutations, and as such, be of benefit in assigning patients for BRCA2 mutation screening.